Robert Przemioslo

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · Full text

Medicine, Internal Medicine, Hepatology +9

The Effect of Benign and Malignant Liver Disease on the Tumour Markers CA19-9 and CEA

Susan Maestranzi, Robert Przemioslo, Hugh Mitchell et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1998 · 130 citations

Medicine, Oncology, Pathology +12

Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody.

Robert Przemioslo, Knut E. A. Lundin, Ludvig M. Sollid et al. · Gut · 1995 · 116 citations · Full text

Life Sciences, Immunology, Pathology +17

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu et al. · Gastroenterology · 2022 · 101 citations · Full text

Medicine, Internal Medicine, Surgery +17

Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry.

Robert Przemioslo, M Kontakou, Valério Nobili et al. · Gut · 1994 · 98 citations · Full text

Life Sciences, Immunology, Pathology +16